BLOG

Thoughtful Insights On The World We Live In

Mergers and Acquisitions

BAGCHI LAW ASSISTS TRIANGLE INSIGHTS GROUP IN ITS SALE TO TRIALCARD

MORRISVILLE, NC – TrialCard Incorporated, a full-service life sciences company, announced the acquisition of Triangle Insights Group. With this transaction, TrialCard adds a team of experienced professionals who will help continue to provide the highest levels of service.  “The addition of Triangle Insights Group to the TrialCard platform is a huge win for the life sciences industry and patients in general,” said Scott Dulitz, President and Chief Strategy Officer at TrialCard.  “Commercialization and operational considerations are becoming increasingly important during the early pre-approval stages of a product’s lifecycle.  Our blended team of experts will be well-positioned to provide both the strategic insights and executional excellence to successfully launch and commercialize new products.”

Having worked with Triangle Insights Group since its inception, Bagchi Law is pleased to have assisted Triangle Insights Group in connection with its acquisition.  “Over the last nine years, we have been delighted to work with Triangle Insights Group’s founders in the launch, growth, and ultimate sale of their dynamic services business.  We enjoy helping our clients to navigate the unpredictable waters of an acquisition from beginning to end,” said Neil Bagchi, Managing Attorney at Bagchi Law.

Triangle Insights Group offers a full suite of consulting services, including R&D and portfolio strategy, new product planning and commercialization support, and extensive pricing and market access expertise and insights.  Headquartered in Durham, North Carolina, with offices in New York City and San Francisco, Triangle Insights Group’s 50+ consultants combine deep knowledge of the life sciences industry across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking.  Recommendations from Triangle Insights Group are original, relevant to the evolving industry landscape, and supported by rigorous analytics.  The company, founded in 2013, supports clients in the biopharmaceutical, diagnostics, and medical device industries, with experience in every therapeutic area and more than 150 indications.  TrialCard is pleased to announce that all TIG partners and employees will be retained by TrialCard post-acquisition.  The deal marks TrialCard’s seventh acquisition since entering a partnership with Odyssey Investment Partners, LLC in November 2017.


About Bagchi Law

Bagchi Law is a team of highly skilled attorneys and professionals who work together, combining 100 years of experience, expertise, and industry knowledge. We approach your legal and business needs from every angle while assessing risks and advising on issues that could impact your organization’s growth for years to come. Our team’s diverse background and experience ensure that our clients receive the highest level of care and counsel. For more information about Bagchi Law, please visit www.bagchilaw.com

About TrialCard

TrialCard Incorporated is a full-service life sciences commercialization company that provides comprehensive solutions that span the entire biopharmaceutical value chain.  In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial supply management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights.  Founded in 2000, TrialCard provides commercialization support for more than 400 life science customers and has connected over 36 million patients with more than $22 billion in branded drug savings to date.  The company is headquartered in Morrisville, North Carolina.  For more information about TrialCard, please visit www.trialcard.com.

About Triangle Insights Group

Triangle Insights Group is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders.  The firm’s approach combines deep industry knowledge with strong analytical rigor to drive strategic decision-making across client domains.  Triangle’s expertise encompasses key therapeutic areas (oncology, CNS, cell, and gene therapy) and relevant industry disciplines (pricing and market access, new product planning, and commercial strategy).  For more information, visit www.triangleinsightsgroup.com.

Related

Why Growing Companies Choose Fractional CISOs: An Interview with Stacey Robinson of GP Tech Advisors

In today’s digital landscape, growing companies face mounting pressure to demonstrate cybersecurity maturity. Whether it’s to win deals, attract investment, or pass audits, the need for robust security leadership is…

>>

Choosing the Right State for Your Business, Part 1: Formation, Laws, and Key Considerations

Forming a new business is a detailed undertaking–there is a lot to consider; a great many pieces to the puzzle. Some choices you make can be changed later with relative…

>>

Artificial Intelligence Startup: The Importance of DueDiligence in Preparing for M&A, Fundraising, or LicensingDeals

Artificial intelligence (“AI”) is everywhere, and it shows no signs of slowing down. Global investment in AI technologies continues to soar; in fact, funding for generative AI startups surged to…

>>

Just Getting Started with Cybersecurity: A Conversation with Stacey Robinson of GP Tech Advisors

Cybersecurity is no longer a luxury or “nice to have.” It’s a critical part of doing business even in the earliest stages. But for startups and small businesses, it can…

>>

2025 Fundraising Forecast: What Businesses and Founders Need to Know

The fundraising landscape in 2025 is rapidly evolving, with shifting investor expectations, rising sector demand, and promising signals for both national and local startup ecosystems. Whether you are an entrepreneur…

>>

Part 2: Expanding and Relocating Your Business: Navigating Multi-State and Global Operations

You’ve chosen a state in which to incorporate, established a business structure, and now you’re busy selling your product or service to satisfied clients and customers. The business you’ve nurtured…

>>

THE LATEST

Artificial Intelligence Startup: The Importance of DueDiligence in Preparing for M&A, Fundraising, or LicensingDeals

Artificial intelligence (“AI”) is everywhere, and it shows no signs of slowing down. Global investment in AI technologies continues to…

Why Growing Companies Choose Fractional CISOs: An Interview with Stacey Robinson of GP Tech Advisors

In today’s digital landscape, growing companies face mounting pressure to demonstrate cybersecurity maturity. Whether it’s to win deals, attract investment,…

Just Getting Started with Cybersecurity: A Conversation with Stacey Robinson of GP Tech Advisors

Cybersecurity is no longer a luxury or “nice to have.” It’s a critical part of doing business even in the…

Contact Us

Let's challenge the default together